AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29618772 — intervention group
Group type: COMPARATOR
Intervention: Well-watered plants
Number of subjects: 0
Study 27045953 — intervention group
Group type: EXPERIMENTAL
Intervention: Engage in Education‐London (EiE‐L) intervention
Number of subjects: 742
Study 27045953 — intervention group
Group type: COMPARATOR
Intervention: Employability seminar (control)
Number of subjects: 742
Study 25193590 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey, antibiotic, and acetaminophen
Number of subjects: 80
Study 25193590 — intervention group
Group type: COMPARATOR
Intervention: Antibiotic and acetaminophen
Number of subjects: 80
Study 22006408 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegobuvir 40 mg BID + GS-9256 75 mg BID
Number of subjects: 46
Study 22006408 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegobuvir 40 mg BID + GS-9256 75 mg BID + RBV 1,000-1,200 mg daily
Number of subjects: 46
Study 22006408 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegobuvir 40 mg BID + GS-9256 75 mg BID + Peg-IFN alpha-2a (180 μg once-weekly) + RBV
Number of subjects: 46
Study 22006408 — intervention group
Group type: COMPARATOR
Intervention: All groups received Peg-IFN/RBV after 28 days
Number of subjects: 46
Study 19556519 — intervention group
Group type: EXPERIMENTAL
Intervention: Patsari stove
Number of subjects: 552
Study 19556519 — intervention group
Group type: COMPARATOR
Intervention: Open fire
Number of subjects: 552
Study 17526634 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 0
Study 17526634 — intervention group
Group type: EXPERIMENTAL
Intervention: Acamprosate
Number of subjects: 0
Study 16781159 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 66
Study 16781159 — intervention group
Group type: COMPARATOR
Intervention: Closed treatment
Number of subjects: 66
Study 15061623 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination against influenza
Number of subjects: 301
Study 15061623 — intervention group
Group type: COMPARATOR
Intervention: Control (unvaccinated)
Number of subjects: 301
Study 10673254 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole 0.5 mg/kg infused intravenously for 3 minutes immediately before reperfusion during primary PTCA.
Number of subjects: 61
Study 10673254 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole 0.5 mg/kg infused intravenously while continuous ECG recordings were obtained.
Number of subjects: 61
Study 10673254 — intervention group
Group type: COMPARATOR
Intervention: Nondipyridamole (non-DP) group.
Number of subjects: 61
Study 9139621 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein (LDL) apheresis for 59 months (Liposorber system, Kaneka, Japan) and 19 months (immunoadsorption system, special Lp(a) columns; Lipopak; Pocard, Russia)
Number of subjects: 2
Study 1848567 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine rinse
Number of subjects: 16
Study 1848567 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline rinse
Number of subjects: 16
Study 1848567 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% SLS rinse
Number of subjects: 16
Study 1848567 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% triclosan rinse
Number of subjects: 16
Study 6340825 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus immunotherapy with BCG-CWS
Number of subjects: 138
Study 6340825 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 138
Study 6340825 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 138
Study 31944339 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise and dietary therapy (PED-t)
Number of subjects: 149
Study 31944339 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 149
Study 31154599 — intervention group
Group type: EXPERIMENTAL
Intervention: PBM + immediate loading (IL)
Number of subjects: 19
Study 31154599 — intervention group
Group type: EXPERIMENTAL
Intervention: PBM + delayed loading (DL)
Number of subjects: 19
Study 31154599 — intervention group
Group type: COMPARATOR
Intervention: IL only
Number of subjects: 19
Study 31154599 — intervention group
Group type: COMPARATOR
Intervention: DL only
Number of subjects: 19
Study 31154599 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 19
Study 28559516 — intervention group
Group type: EXPERIMENTAL
Intervention: ATT with cholecalciferol
Number of subjects: 300
Study 28559516 — intervention group
Group type: COMPARATOR
Intervention: ATT
Number of subjects: 300
Study 26659931 — intervention group
Group type: EXPERIMENTAL
Intervention: Crisaborole topical ointment 2% applied twice daily (BID)
Number of subjects: 86
Study 26659931 — intervention group
Group type: EXPERIMENTAL
Intervention: Crisaborole topical ointment 0.5% or 2% applied once daily (QD)
Number of subjects: 86
Study 26659931 — intervention group
Group type: EXPERIMENTAL
Intervention: Crisaborole topical ointment 0.5% or 2% applied twice daily (BID)
Number of subjects: 86
Study 22971742 — intervention group
Group type: EXPERIMENTAL
Intervention: midazolam + tramadol (1 mg/kg)
Number of subjects: 87
Study 22971742 — intervention group
Group type: EXPERIMENTAL
Intervention: midazolam + saline
Number of subjects: 87
Study 22971742 — intervention group
Group type: COMPARATOR
Intervention: Control (no additional medication)
Number of subjects: 87
Study 21514637 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (10-22.5 mg/wk)
Number of subjects: 42
Study 21514637 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (1.5-2.5 mg/kg/d)
Number of subjects: 42
Study 21514637 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate and Azathioprine
Number of subjects: 42
Study 21514637 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine
Number of subjects: 42
Study 18030515 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID therapy followed by methotrexate (MTX) for 3 months after 3 months of NSAID therapy
Number of subjects: 35
Study 18030515 — intervention group
Group type: COMPARATOR
Intervention: Combination of NSAID and MTX for the entire 6-month period
Number of subjects: 35
Study 17205826 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound decoctum of Tripterygium wilfordii (TW) and liquorice
Number of subjects: 120
Study 17205826 — intervention group
Group type: COMPARATOR
Intervention: Tripterygium wilfordii ployglycosidium tablets
Number of subjects: 120
Study 14638353 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamins E and C (1000 IU and 1000 mg, respectively) daily for 6 months
Number of subjects: 49
Study 14638353 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 11125871 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 12 mg + Caffeine 250 mg
Number of subjects: 108
Study 11125871 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 12 mg + Caffeine 125 mg
Number of subjects: 108
Study 11125871 — intervention group
Group type: COMPARATOR
Intervention: Midazolam 12 mg
Number of subjects: 108
Study 11125871 — intervention group
Group type: COMPARATOR
Intervention: Caffeine 250 mg
Number of subjects: 108
Study 11125871 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 300 mg
Number of subjects: 108
Study 11125871 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 15 mg
Number of subjects: 108
Study 8797215 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous-Interleaved-Sampling (CIS) strategy
Number of subjects: 0
Study 8797215 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectral-Peak (SPEAK) strategy
Number of subjects: 0
Study 8797215 — intervention group
Group type: COMPARATOR
Intervention: Multipeak (MPEAK) strategy
Number of subjects: 0
Study 1624973 — intervention group
Group type: EXPERIMENTAL
Intervention: Refraining from consuming soft drinks
Number of subjects: 1009
Study 1624973 — intervention group
Group type: EXPERIMENTAL
Intervention: Refraining from consuming soft drinks (for those consuming phosphoric acid drinks)
Number of subjects: 1009
Study 1624973 — intervention group
Group type: EXPERIMENTAL
Intervention: Refraining from consuming soft drinks (for those consuming citric acid drinks)
Number of subjects: 1009
Study 6439836 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐fluorouracil (5‐FU) and methyl‐CCNU
Number of subjects: 222
Study 6439836 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐FU, Adriamycin, and methyl‐CCNU
Number of subjects: 222
Study 6439836 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐FU, Adriamycin, and mitomycin C
Number of subjects: 222
Study 6439836 — intervention group
Group type: EXPERIMENTAL
Intervention: Adriamycin and mitomycin C alone
Number of subjects: 222
Study 6439836 — intervention group
Group type: COMPARATOR
Intervention: Adriamycin and mitomycin C
Number of subjects: 222
Study 31092895 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly carfilzomib 70 mg/m2 (Kd70 mg/m2)
Number of subjects: 469
Study 31092895 — intervention group
Group type: COMPARATOR
Intervention: Twice-weekly carfilzomib 27 mg/m2 (Kd27 mg/m2)
Number of subjects: 469
Study 28259322 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination analgesics
Number of subjects: 0
Study 28259322 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27185684 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforced tracheal tubes
Number of subjects: 76
Study 27185684 — intervention group
Group type: COMPARATOR
Intervention: Standard polyvinyl chloride tracheal tubes
Number of subjects: 76
Study 25150183 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted temperature management (TTM) at 33 °C
Number of subjects: 169
Study 25150183 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted temperature management (TTM) at 36 °C
Number of subjects: 169
Study 25150183 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified, but implied as TTM not applied)
Number of subjects: 169
Study 22097972 — intervention group
Group type: COMPARATOR
Intervention: Adefovir dipivoxil (ADV) 10 mg daily
Number of subjects: 480
Study 19638620 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediagnostic serum concentration of soluble CD30 (sCD30)
Number of subjects: 234
Study 19638620 — intervention group
Group type: COMPARATOR
Intervention: Control group (first quartile of sCD30)
Number of subjects: 234
Study 17941284 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexofenadine hydrochloride, 30 mg, twice daily for 2 weeks
Number of subjects: 453
Study 17941284 — intervention group
Group type: COMPARATOR
Intervention: Placebo, twice daily for 2 weeks
Number of subjects: 453
Study 16360521 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar radiofrequency dissection tonsillectomy (BRDT)
Number of subjects: 200
Study 16360521 — intervention group
Group type: COMPARATOR
Intervention: Cold dissection tonsillectomy (CDT)
Number of subjects: 200
Study 11562661 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelatin-coated Dacron (GEL-D) grafts (n = 109)
Number of subjects: 315
Study 11562661 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen-coated Dacron (COL-D) grafts (n = 100)
Number of subjects: 315
Study 11562661 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretch polytetrafluoroethylene (PTFE) grafts (n = 106)
Number of subjects: 315
Study 11562661 — intervention group
Group type: COMPARATOR
Intervention: Gelatin-coated Dacron (GEL-D) grafts
Number of subjects: 315
Study 11562661 — intervention group
Group type: COMPARATOR
Intervention: Collagen-coated Dacron (COL-D) grafts
Number of subjects: 315
Study 11562661 — intervention group
Group type: COMPARATOR
Intervention: Stretch polytetrafluoroethylene (PTFE) grafts
Number of subjects: 315
Study 11562661 — intervention group
Group type: COMPARATOR
Intervention: Dacron grafts (GEL-D and COL-D combined)
Number of subjects: 315
Study 9622279 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5, 1 or 2 mg/day of oral micronized 17beta‐estradiol
Number of subjects: 18
Study 7841755 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvia miltiorrhiza (SM)
Number of subjects: 30
Study 7841755 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 30
Study 7841755 — intervention group
Group type: COMPARATOR
Intervention: Control (22 healthy subjects)
Number of subjects: 30
Study 3216364 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefamandole (1-g intravenous dose)
Number of subjects: 223
Study 3216364 — intervention group
Group type: COMPARATOR
Intervention: Cefotaxime (1-g intravenous dose)
Number of subjects: 223
Study 30479292 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 30
Study 30479292 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard of care plus increased educational information regarding bowel preparation
Number of subjects: 30
Study 30479292 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard of care plus increased educational information regarding bowel preparation plus an anti-flatulent medication
Number of subjects: 30
Study 27641791 — intervention group
Group type: EXPERIMENTAL
Intervention: 4h sleep with 0.28Hz horizontal linear oscillation
Number of subjects: 4
Study 27641791 — intervention group
Group type: COMPARATOR
Intervention: 8h sleep with stationary conditions
Number of subjects: 4
Study 27641791 — intervention group
Group type: EXPERIMENTAL
Intervention: 4h sleep with stationary conditions
Number of subjects: 4
Study 27641791 — intervention group
Group type: COMPARATOR
Intervention: 8h sleep with 0.28Hz horizontal linear oscillation
Number of subjects: 4
Study 25012163 — intervention group
Group type: EXPERIMENTAL
Intervention: ApoA2 (fourth quartile)
Number of subjects: 1255
Study 25012163 — intervention group
Group type: COMPARATOR
Intervention: HDL cholesterol and apoA1 and apoC3 quartiles
Number of subjects: 1255
Study 25012163 — intervention group
Group type: EXPERIMENTAL
Intervention: ApoA2
Number of subjects: 1255
Study 24125675 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance plus nerve stimulation (group US-NS)
Number of subjects: 166
Study 24125675 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound guidance alone (group US)
Number of subjects: 166
Study 21914207 — intervention group
Group type: EXPERIMENTAL
Intervention: Written invitation letter to spouses of new antenatal attendees
Number of subjects: 1060
Study 21914207 — intervention group
Group type: COMPARATOR
Intervention: Information letter and leaflet concerning antenatal care (Control)
Number of subjects: 1060
Study 19028275 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy for early-stage Hodgkin's lymphoma
Number of subjects: 0
Study 19028275 — intervention group
Group type: EXPERIMENTAL
Intervention: Contemporary therapeutic approaches
Number of subjects: 0
Study 19028275 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0
Study 17163273 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg/day + Amoxicillin 1500 mg/day + Clarithromycin 400 mg/day
Number of subjects: 288
Study 17163273 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg/day + Amoxicillin 1500 mg/day + Clarithromycin 800 mg/day
Number of subjects: 288
Study 14586049 — intervention group
Group type: EXPERIMENTAL
Intervention: RDS group (neutrophil apoptosis on day 7 BAL)
Number of subjects: 32
Study 14586049 — intervention group
Group type: COMPARATOR
Intervention: BAL fluid from RDS patients (day 1)
Number of subjects: 32
Study 14586049 — intervention group
Group type: COMPARATOR
Intervention: BAL fluid from RDS patients (day 2)
Number of subjects: 32
Study 14586049 — intervention group
Group type: EXPERIMENTAL
Intervention: ECMO survivors (day 1)
Number of subjects: 32
Study 10760376 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid mixture without tryptophan (depletion group)
Number of subjects: 24
Study 10760376 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 24
Study 9032182 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma hypoxanthine levels in ARDS nonsurvivors (37.48 +/- 3.1 microM)
Number of subjects: 4
Study 9032182 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma hypoxanthine levels in ARDS survivors (15.24 +/- 2.09 microM)
Number of subjects: 4
Study 9032182 — intervention group
Group type: COMPARATOR
Intervention: Plasma hypoxanthine levels in patients undergoing pulmonary resection (9.22 +/- 1.89 microM)
Number of subjects: 4
Study 9032182 — intervention group
Group type: COMPARATOR
Intervention: Plasma hypoxanthine levels in patients with sepsis (1.12 +/- 0.69 microM)
Number of subjects: 4
Study 9032182 — intervention group
Group type: COMPARATOR
Intervention: Plasma hypoxanthine levels in normal healthy controls (1.43 +/- 0.38 microM)
Number of subjects: 4
Study 8314475 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose interferon (10 million units (MU) given six times a week for two weeks followed by 12 weeks of thrice weekly dosing
Number of subjects: 126
Study 8314475 — intervention group
Group type: COMPARATOR
Intervention: Eight weeks of 10 MU interferon six times a week
Number of subjects: 126
Study 8314475 — intervention group
Group type: COMPARATOR
Intervention: Four weeks of 10 MU six times a week followed by eight weeks of thrice weekly dosing
Number of subjects: 126
Study 2963306 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of a third generation cephalosporin (cefotaxime or ceftazidime) and a new quinolone (pefloxacin)
Number of subjects: 33
Study 31420665 — intervention group
Group type: EXPERIMENTAL
Intervention: PS-LED (cool poultry specific LED)
Number of subjects: 20
Study 31420665 — intervention group
Group type: COMPARATOR
Intervention: ICD (incandescent)
Number of subjects: 20
Study 31420665 — intervention group
Group type: EXPERIMENTAL
Intervention: Short/non-intermittent photoperiod (8L:16D)
Number of subjects: 20
Study 31420665 — intervention group
Group type: COMPARATOR
Intervention: Regular/intermittent photoperiod (2L:2D)
Number of subjects: 20
Study 31420665 — intervention group
Group type: EXPERIMENTAL
Intervention: Strain A and B
Number of subjects: 20
Study 31420665 — intervention group
Group type: EXPERIMENTAL
Intervention: Feed conversion, fat, tender, and yield
Number of subjects: 20
Study 31420665 — intervention group
Group type: EXPERIMENTAL
Intervention: Photoperiod, light sources, or their interactions
Number of subjects: 20
Study 28675520 — intervention group
Group type: EXPERIMENTAL
Intervention: SB5
Number of subjects: 189
Study 28675520 — intervention group
Group type: COMPARATOR
Intervention: EU‐ADL
Number of subjects: 189
Study 28675520 — intervention group
Group type: COMPARATOR
Intervention: US‐ADL
Number of subjects: 189
Study 26371168 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (81 mg)
Number of subjects: 12
Study 26371168 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 24148712 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 53
Study 24148712 — intervention group
Group type: COMPARATOR
Intervention: Control (no Tranexamic acid)
Number of subjects: 53
Study 21340523 — intervention group
Group type: EXPERIMENTAL
Intervention: MISPTT (minimally invasive stereotactic puncture and thrombolysis therapy)
Number of subjects: 122
Study 21340523 — intervention group
Group type: COMPARATOR
Intervention: Conventional craniotomy (CC)
Number of subjects: 122
Study 19794171 — intervention group
Group type: EXPERIMENTAL
Intervention: Translaminar screws
Number of subjects: 120
Study 19794171 — intervention group
Group type: COMPARATOR
Intervention: Transforaminal lumbar interbody fusion
Number of subjects: 120
Study 17448764 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection
Number of subjects: 42
Study 17448764 — intervention group
Group type: COMPARATOR
Intervention: Myectomy of the internal anal sphincter (IAS)
Number of subjects: 42
Study 15337974 — intervention group
Group type: EXPERIMENTAL
Intervention: Short 30‐G x 0.40 x 6 mm gauge needle
Number of subjects: 37
Study 15337974 — intervention group
Group type: COMPARATOR
Intervention: Conventional 25‐G x 0.50 x 13 mm gauge needle
Number of subjects: 37
Study 12023755 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar nerve root decompression surgery in elderly patients
Number of subjects: 44
Study 12023755 — intervention group
Group type: COMPARATOR
Intervention: Lumbar nerve root decompression surgery in younger patients (30-50 years)
Number of subjects: 44
Study 12023755 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar nerve root decompression surgery in both groups
Number of subjects: 44
Study 11907928 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous conjugated estrogens (Premarin) and cyclic medroxyprogesterone acetate (Provera)
Number of subjects: 83
Study 11907928 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 7905086 — intervention group
Group type: EXPERIMENTAL
Intervention: Björk-Shiley convexo-concave valves
Number of subjects: 22
Study 7905086 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 degrees valves
Number of subjects: 22
Study 7905086 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 degrees valves
Number of subjects: 22
Study 2689427 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-h preexercise carbohydrate feeding (M-4)
Number of subjects: 7
Study 2689427 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-h preexercise carbohydrate feeding (M-8)
Number of subjects: 7
Study 2689427 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-h preexercise with carbohydrate feedings during exercise (M-4CHO)
Number of subjects: 7
Study 2689427 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-h preexercise with carbohydrate feedings during exercise (M-8CHO)
Number of subjects: 7
Study 141644 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief, intense transcutaneous electrical stimulation
Number of subjects: 0
Study 141644 — intervention group
Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 0
Study 42410 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcal polysaccharide vaccine
Number of subjects: 40
Study 42410 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31162183 — intervention group
Group type: EXPERIMENTAL
Intervention: S2 alar iliac (S2AI) screws
Number of subjects: 64
Study 28385290 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal (HFM)
Number of subjects: 8
Study 28385290 — intervention group
Group type: COMPARATOR
Intervention: Moderate-fat meal (MFM)
Number of subjects: 8
Study 25495720 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 100mg
Number of subjects: 714
Study 25495720 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 300mg
Number of subjects: 714
Study 25495720 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 714